Hepatology:HBV pgRNA用于乙型肝炎相关肝癌的肿瘤分型和预后预测

2017-08-22 MedSci MedSci原创

肝癌组织中复制的乙型肝炎病毒是侵入性较弱、具有转录特性的一种病毒亚型。

乙型肝炎病毒是导致肝细胞癌发病的主要原因。然而,对于乙型肝炎病毒在肝癌组织中的复制却了解很少。本研究纳入99例HBsAg阳性、病毒学得到抑制,接受肿瘤切除或肝移植的肝细胞癌患者,分析肿瘤和配对的非肿瘤肝癌组织中的病毒和细胞参数,对总HBV DNA、RNA、共价闭合环状DNA(cccDNA)、前基因组RNA(PgRNA)等HBV活跃复制标志物进行检测。


结果显示,大多数患者的肿瘤组织和非肿瘤组织中均可检测出乙肝病毒总DNA、RNA;然而,非肿瘤肝组织中cccDNA和PgRNA检出率分别为66%和90%,相比之下,部分肿瘤肝组织中cccDNA和PgRNA的检出率分别为39%和67%。对11例患者游离基因形式的X基因进行测序,结果表明11位患者中肿瘤组织和非肿瘤组织中HBV基因型不同,为HBV在肿瘤组织中复制提供了进一步的证据。肿瘤组织中,pgRNA和cccDNA的检出与无肿瘤微血管侵犯和良好预后相关。使用Agilent微阵列对基因表达进行分析,pgRNA阳性的肝癌患者,细胞周期、DNA修复水平较低,表达HBV受体-NTCP,表明肿瘤分化良好。

肝癌组织中复制的乙型肝炎病毒是侵入性较弱、具有转录特性的一种病毒亚型。前基因组RNA来源于非整合的、完整的乙型肝炎病毒基因组,是病毒复制和预后的敏感指标。

原始出处:


Halgand B, Desterke C, Riviere L, et al. Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant. Hepatology, 2017 Aug 12. doi: 10.1002/hep.29463.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1836631, encodeId=dc1418366315a, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8524, encryptionId=f9d08524be, topicName=HBV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Mon Jun 25 01:34:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1825622, encodeId=e78018256221d, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23394, encryptionId=1a942339426, topicName=乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Nov 06 05:34:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426804, encodeId=94c6142680426, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Aug 24 13:34:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615317, encodeId=7949161531ec9, content=<a href='/topic/show?id=29ae826375' target=_blank style='color:#2F92EE;'>#GRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8263, encryptionId=29ae826375, topicName=GRN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f68619606350, createdName=ms7517674339485982, createdTime=Thu Aug 24 13:34:00 CST 2017, time=2017-08-24, status=1, ipAttribution=)]
    2018-06-25 klivis
  2. [GetPortalCommentsPageByObjectIdResponse(id=1836631, encodeId=dc1418366315a, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8524, encryptionId=f9d08524be, topicName=HBV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Mon Jun 25 01:34:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1825622, encodeId=e78018256221d, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23394, encryptionId=1a942339426, topicName=乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Nov 06 05:34:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426804, encodeId=94c6142680426, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Aug 24 13:34:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615317, encodeId=7949161531ec9, content=<a href='/topic/show?id=29ae826375' target=_blank style='color:#2F92EE;'>#GRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8263, encryptionId=29ae826375, topicName=GRN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f68619606350, createdName=ms7517674339485982, createdTime=Thu Aug 24 13:34:00 CST 2017, time=2017-08-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1836631, encodeId=dc1418366315a, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8524, encryptionId=f9d08524be, topicName=HBV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Mon Jun 25 01:34:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1825622, encodeId=e78018256221d, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23394, encryptionId=1a942339426, topicName=乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Nov 06 05:34:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426804, encodeId=94c6142680426, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Aug 24 13:34:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615317, encodeId=7949161531ec9, content=<a href='/topic/show?id=29ae826375' target=_blank style='color:#2F92EE;'>#GRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8263, encryptionId=29ae826375, topicName=GRN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f68619606350, createdName=ms7517674339485982, createdTime=Thu Aug 24 13:34:00 CST 2017, time=2017-08-24, status=1, ipAttribution=)]
    2017-08-24 gwc384
  4. [GetPortalCommentsPageByObjectIdResponse(id=1836631, encodeId=dc1418366315a, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8524, encryptionId=f9d08524be, topicName=HBV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87531, createdName=klivis, createdTime=Mon Jun 25 01:34:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1825622, encodeId=e78018256221d, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23394, encryptionId=1a942339426, topicName=乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Nov 06 05:34:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426804, encodeId=94c6142680426, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Thu Aug 24 13:34:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1615317, encodeId=7949161531ec9, content=<a href='/topic/show?id=29ae826375' target=_blank style='color:#2F92EE;'>#GRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8263, encryptionId=29ae826375, topicName=GRN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f68619606350, createdName=ms7517674339485982, createdTime=Thu Aug 24 13:34:00 CST 2017, time=2017-08-24, status=1, ipAttribution=)]